Search

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
GET IN TOUCH

Choosing the Right CRO for In Vivo Research

August 17, 2026

A promising therapeutic candidate eventually reaches a decisive moment: the in vivo study that will shape what happens next. At this stage, choosing a Contract Research Organization (CRO) may appear to be a decision about models, capabilities, timelines, and cost. Yet technical execution alone does not create confidence.

Sponsors also need visibility, responsive scientific guidance, and a partner able to adapt when research takes an unexpected turn. A CRO does more than conduct a study. It becomes an extension of the sponsor’s team, influencing data quality, decision speed, and the direction of the preclinical program.

“We are thoroughly impressed with your level of detail and communication efforts. We thank you and the Aragen team for getting us to this point in the study with confidence that you are doing the very best to achieve a successful study.”

“We have never had communication from a preclinical group at this level in our combined history of drug product development.”

– Dr. Jamie Oliver, Chief Medical Officer, Starton Therapeutics

This experience highlights what differentiates an effective service provider from a true scientific partner. Before committing to a CRO, sponsors should evaluate six factors that can materially influence preclinical success.

1. Scientific expertise beyond model availability

Look for relevant disease biology knowledge, translational perspective, experience with complex studies, and the ability to recommend suitable models, endpoints, and approaches. The right CRO should strengthen the scientific rationale, not simply execute instructions.

2. Robust study design and proactive problem-solving

Study quality is shaped before dosing begins. A strong partner contributes to statistical planning, endpoint selection, biomarker strategy, and risk assessment. Proactive questions and contingency planning can reduce uncertainty and help avoid costly repetition.

3. Communication that builds confidence

Regular updates are valuable, but exceptional communication goes further. It includes detailed observations, early identification of emerging issues, transparent discussion of unexpected findings, and thoughtful interpretation while decisions can still be made.

4. Flexibility without compromising rigor

Research rarely follows a straight line. New findings may require protocol amendments, additional endpoints, or revised timelines. An adaptable CRO responds efficiently while protecting scientific quality, compliance, and study objectives.

5. Data quality with meaningful interpretation

Reliable collection, robust quality systems, and sound analysis are essential. Sponsors also need reports that provide context. The most valuable partners help translate findings into actionable insights that inform candidate selection and next-step decisions.

6. A partnership built for the program, not one study

Long-term collaboration creates scientific continuity and a deeper understanding of sponsor goals. A strategic partner anticipates challenges, shares responsibility for outcomes, and continues adding value as the program evolves.

A Simple CRO Selection Check

  •  Relevant scientific and translational expertise
  • Strong design and risk-mitigation capabilities
  • Proactive, transparent communication
  •  Operational flexibility and responsiveness
  •  High-quality data and decision-ready reporting
  • A collaborative, long-term mindset

The Right CRO Can Accelerate More Than Research

Selecting a CRO is not simply about outsourcing a study. It is about choosing who will help shape critical decisions throughout development. Scientific excellence remains fundamental, but the strongest partnerships are distinguished by trust: trust that the team understands the science, communicates openly, anticipates challenges, and remains invested in the program’s success.

READY TO MOVE YOUR PRECLINICAL PROGRAM FORWARD WITH CONFIDENCE?

Connect with Aragen’s In Vivo Research experts to discuss your scientific objectives, study requirements, and development challenges. Together, we can turn critical preclinical questions into confident next steps and help advance your path toward clinical development.

The best CROs do not just deliver study results. They help sponsors make better decisions, faster, with confidence.

FAQs

A Contract Research Organization provides specialized preclinical research support, which may include study design, animal models, pharmacology studies, data analysis, reporting, and scientific guidance for drug development programs.

Evaluate relevant scientific expertise, disease-area experience, study design support, communication practices, operational flexibility, data-quality systems, and the ability to work as a collaborative long-term partner.

Ask about comparable study experience, model relevance, design and statistical support, communication frequency, quality processes, reporting standards, risk management, timelines, and the team that will support the program.

Transparent, proactive communication gives sponsors visibility into study progress, helps identify risks earlier, supports faster decisions, and maintains alignment when unexpected findings arise.

Study design influences data quality, reproducibility, statistical confidence, translational relevance, and whether results can support informed development decisions.

A strategic partner contributes scientific insight, anticipates challenges, communicates transparently, solves problems collaboratively, and remains aligned with the sponsor’s broader development goals.

An experienced CRO can strengthen study design, reduce avoidable risk, provide earlier visibility into issues, support high-quality data generation, and help sponsors make more confident next-step decisions.

It should clearly present the study methodology, observations, analyses, interpretation, conclusions, and the context needed to inform future research or development decisions.

They support scientific continuity, faster alignment, retained program knowledge, operational efficiency, and relevant guidance as a development program evolves.